Inspire Medical Systems今日盘中股价大涨5.05%,主要是由于公司公布的最新季度业绩超出市场预期。
具体来说,公司截至1月1日的季度调整后每股收益为0.6美元,远高于去年同期亏损0.29美元,也超过分析师平均预期的0.08-0.3美元区间。营收同比增长32.5%至2.03亿美元,也高于分析师预期的1.976亿美元。公司报告的季度净收入达到1850万美元。
得益于业绩的亮眼表现,分析师对公司前景也更趋乐观。过去三个月内,分析师对公司盈利预期上调了约92.4%。目前分析师普遍给予该公司"买入"评级,其中有12家机构给予"强烈买入"或"买入"评级,7家机构评为"持有",没有卖出评级。分析师还普遍上调了对该股未来12个月目标价格的预期。
总的来看,Inspire Medical Systems本次股价大涨与其基本面的持续向好密切相关,充分反映了市场对该公司业务增长前景的看好。分析师调高了未来业绩及股价预期,也成为推动股价上涨的重要因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.